COPD: Page 20

FDA approves ensifentrine for COPD maintenance treatment
Agency action makes Ohtuvayre the first novel mechanism for COPD care in 20 years.
July 2, 2024
Ensifentrine mechanism of action.
FDA grants clearance for clinical deterioration software
New suite can accurately identify high-risk hospitalized patients across conditions, including COPD.
July 2, 2024
Blurred image of a doctor in the background pressing an AI button in the foreground.
Prevalence of COPD is higher in LGBTQ+ communities
New journal articles call for more research, educational efforts in these communities.
June 27, 2024
Image of a stethoscope on a rainbow flag.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Increased omega-3 levels may benefit patients with COPD
Omega-3 fatty acids have previously been linked to anti-inflammatory responses in COPD.
June 27, 2024
Image of healthy foods with the words omega 3 in the middle.
Comorbidities lead to higher risk of prolonged ventilation in COPD patients
Study finds that risk is more than five times higher.
June 19, 2024
An older woman pictured with an oxygen mask receiving ventilation treatment.
Ensifentrine could add benefits for COPD patients
Evidence report suggests the treatment could work well when paired with other treatments.
June 19, 2024
Puzzle pieces forming a pair of lungs to represent lung treatment.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Simple exercise reduces COPD patients’ risk of hospitalization
Exercising on a treadmill can nearly cut in half one’s risk of being readmitted to the hospital.
June 13, 2024
Photo of feet in running shoes on a treadmill.
Human trials begin in ultrasound system for COPD treatment
The first two patients are being tested in Tbilisi, Georgia, to confirm the safety of the platform.
June 13, 2024
Company Logo for AerWave Medical
FDA delays priority review of Dupixent by three months
A decision on the potential COPD treatment has been pushed back to September 2024.
June 5, 2024
A blue circle with FDA (Food and Drug Administration) printed on it.
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
Study unveils safe beta-blocker solution for COPD patients
Results presented at ATS 2024 show that bisoprolol can be prescribed to patients with COPD for cardiac disease treatment.
June 5, 2024
Image of a monitor showing patient vital signs.
ATS 2024: ASLAN presents data on eblasakimab
Transitional data was presented on a head-to-head study of eblasakimab and dupilumab in a human tissue model.
May 30, 2024
Background image of stethoscope with graphics of charts and data in the foreground.
Fasenra could have potential for COPD
The FDA-approved asthma medication is currently in trials for additional uses.
May 30, 2024
Black doctor examining a tablet next to a microscope.
Previous Page
Page 20 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial